Self-Identification Program

Recruiting N/A Interventional Study
Major Depressive Disorder Third Wave Cognitive Behavioral Therapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
86 (estimated)
Sponsor
University Hospital, Montpellier · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% b…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder Exclusion Criteria: * Patients with a psychotic disorder * Patients with active thoughts of suicide with intention to carry …
Contacts

Déborah Ducasse, MD

+33 4 67 33 28 29

d-ducasse@chu-montpellier.fr

CONTACT

Véronique Brand Arpon, IDE

v-arpon@chu-montpellier.fr

CONTACT